Global Infection Control Market Research Report By Product Type (Disinfectants, Infection Control Supplies, Sterilization Equipment, Personal Protective Equipment), By Application (Hospitals, Pharmaceuticals, Research Laboratories, Food Industry), By End Use (Healthcare, Commercial, Residential), By Distribution Channel (Online, Offline, Direct Sales) and By Regional (North America, Europe, South America, Asia-Pacific, Middle-East and Africa)-Forecast to 2035

Infection Control Market Overview

As per MRFR analysis, the Infection Control Market Size was estimated at 33.75 (USD Billion) in 2023.The Infection Control Market Industry is expected to grow from 35.65(USD Billion) in 2024 to 65.2 (USD Billion) by 2035. The Infection Control Market CAGR (growth rate) is expected to be around 5.64% during the forecast period (2025-2035).

Key Infection Control Market Trends Highlighted

The Global Infection Control Market is experiencing substantial growth, which is primarily due to the growing awareness of infection prevention and control measures, particularly in healthcare environments. The global aging population and the increase in chronic diseases have resulted in a greater emphasis on the preservation of secure environments in hospitals and clinics. Additionally, the necessity for efficient infection control solutions has been exacerbated by government initiatives that are designed to fortify the healthcare infrastructure. The increasing investment in advanced technologies, such as automated disinfection systems and innovative sterilization methods, which improve the efficiency and efficacy of infection prevention, is a notable trend. The development of personalized infection control protocols that are tailored to the unique requirements of patients and healthcare settings is one of the primary opportunities in the Global Infection Control Market. This method not only improves patient outcomes but also ensures that infection control guidelines are adhered to. In addition, the emergence of telehealth and remote monitoring offers an opportunity to incorporate infection control practices into digital platforms, enabling the real-time monitoring and management of infection risks. In recent years, there has been a growing emphasis on sustainable and eco-friendly infection control products as healthcare providers strive to reduce their environmental impact while maintaining high standards of care.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Infection Control Market Drivers

Rising Instances of Healthcare-Associated Infections (HAIs)

The Global Infection Control Market Industry is witnessing a significant growth driven by the increasing incidence of healthcare-associated infections (HAIs). According to the Centers for Disease Control and Prevention, approximately 1 in 31 hospital patients has at least one infection that was acquired while receiving medical care. This statistic highlights the critical need for effective infection control strategies. Major organizations, such as the World Health Organization, have been advocating for improved infection prevention measures in healthcare settings globally, as they recognize that HAIs contribute to prolonged hospital stays, increased medical costs, and higher mortality rates.The financial burden on healthcare systems cannot be understated; for instance, it is estimated that HAIs can cost hospitals between 28 to 45 billion USD per year in the United States alone. This alarming trend is propelling the demand for infection control products and services, thus boosting the Global Infection Control Market.

Government Initiatives to Improve Infection Prevention

Government initiatives across various countries are playing a pivotal role in driving the Global Infection Control Market Industry. For instance, numerous governments have launched campaigns aimed at reducing HAIs and enhancing infection control practices in healthcare facilities. The U.S. Department of Health and Human Services has outlined National Action Plans that prioritize infection control advancements, promoting adherence to best practices.In Europe, the European Centre for Disease Prevention and Control emphasizes the necessity for infection control protocols, which has led to an increase in funding and resources allocated to infection prevention programs. These concerted efforts are likely to result in a more robust regulatory framework and increased investment in infection prevention technologies, thereby spurring the growth of the market.

Growing Demand for Advanced Sterilization Technologies

The rising demand for advanced sterilization technologies is another significant driver of the Global Infection Control Market Industry. As hospitals and clinics strive for higher standards of safety and cleanliness, the need for innovative sterilization solutions is becoming more apparent. Technologies such as ethylene oxide sterilization and plasma sterilization are gaining traction due to their effectiveness in eliminating microbes. According to a report by the World Health Organization, approximately 80 percent of surgical procedures worldwide are at a heightened risk for infection, emphasizing the urgent need for efficient sterilization practices.The integration of advanced sterilization technologies into healthcare facilities is supported by leading companies like Steris Corporation and 3M, which invest extensively in Research and Development to introduce new sterilization solutions. This trend not only enhances patient safety but also cultivates a more favorable environment for market expansion.

Infection Control Market Segment Insights

Infection Control Market Product Type Insights

The Global Infection Control Market is structured around several key product types that are crucial in combating infections in various environments. In 2024, the overall market is expected to be valued at 35.65 USD Billion, demonstrating the increasing focus on health standards and hygiene. Among the product types, Disinfectants hold a significant share, valued at 10.5 USD Billion in 2024 and projected to reach 20.3 USD Billion in 2035. This segment dominates due to the urgent need for effective cleaning and sanitization solutions in hospitals, clinics, and industries, especially highlighted during the recent pandemic.Infection Control Supplies account for another major portion of the market, valued at 12.9 USD Billion in 2024 and anticipated to grow to 25.1 USD Billion by 2035.This growth reflects the rising demand for various supplies like gloves, masks, and other consumables that are essential for protecting individuals from infection spread. Sterilization Equipment is valued at 6.3 USD Billion in 2024 and is expected to increase to 12.1 USD Billion in 2035. This segment's importance cannot be understated; it ensures the safety of surgical and medical instruments, securing patient safety and operational success in medical facilities.Lastly, the Personal Protective Equipment segment, valued at 6.9 USD Billion in 2024, illustrates the critical nature of protective gear in laboratory and healthcare settings, with a slight rise to 7.5 USD Billion by 2035. Despite its lower valuation compared to other segments, the significance of Personal Protective Equipment remains evident as it directly contributes to the prevention of infection transmission in environments where exposure risks are high. Overall, the Global Infection Control Market segmentation highlights various product types play essential roles in health and safety protocols, making them indispensable assets for healthcare infrastructure globally.The growth opportunities in these segments arise from increased regulations and higher awareness about infection prevention strategies, making the market ripe for innovation and development.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Infection Control Market Application Insights

The Global Infection Control Market is poised for significant growth, with a market value expected to reach 35.65 billion USD by 2024. The increasing demand for effective infection control solutions within various applications largely drives this growth. Hospitals play a crucial role in this ecosystem, as they require stringent infection control measures to ensure patient safety and quality of care, thus dominating the overall market landscape. The Pharmaceuticals sector is also a key contributor, necessitating rigorous infection control protocols to protect drugs and maintain research integrity.Research Laboratories demand high standards of cleanliness to prevent contamination and ensure accurate results, making them pivotal in the advancement of medical science. Furthermore, the Food Industry must adhere to strict hygiene standards to safeguard public health, highlighting its importance in the overall Infection Control Market. With a focus on these applications, the market witnesses continuous innovation, propelled by the need for advanced technologies and adherence to regulatory standards that support overall health safety and disease prevention.

Infection Control Market End-Use Insights

The Global Infection Control Market focuses significantly on diverse End Use applications, which are crucial for engaging with market demands. By 2024, the market is projected to reach a valuation of 35.65 billion USD, underlining the growing emphasis on infection control across various environments. The Healthcare sector remains a pivotal aspect of this market due to its necessity for stringent infection control protocols to ensure patient safety and minimize healthcare-associated infections. The Commercial domain is also vital, as businesses increasingly adopt infection control measures to protect employees and consumers, enhancing workplace safety in light of recent epidemics.Additionally, Residential usage highlights the importance of maintaining hygiene at home, particularly with rising awareness about cleanliness and health in everyday environments. As the Global Infection Control Market revenue evolves, factors such as technological advancements, the demand for cleaner and safer environments, and increasing regulatory compliance will drive growth. Global statistics highlight a more informed consumer base, positioning infection control as a fundamental necessity in ensuring public health and safety across all sectors.This market's expansion provides opportunities for innovation and improvement in infection control methodologies.

Infection Control Market Distribution Channel Insights

The Global Infection Control Market has showcased a significant focus on the Distribution Channel segment, as it plays a crucial role in reaching healthcare providers and consumers. By 2024, the market is expected to be valued at 35.65 billion USD, reflecting the increasing demand for infection control products across various settings. The Distribution Channel is primarily categorized into Online, Offline, and Direct Sales, with each method utilizing distinct strategies to meet the needs of different market segments. Online channels have gained traction due to advancements in technology and the rising trend of e-commerce, facilitating easy access to infection control solutions.Offline channels continue to thrive, especially within hospitals and clinics, where direct sales representatives offer personalized assistance and support. The importance of Direct Sales cannot be overstated, as it allows manufacturers to establish direct relationships with healthcare facilities, ensuring better product education and service. As the Global Infection Control Market data evolve, companies in this field must adapt their distribution strategies to leverage growing opportunities and navigate challenges effectively. With a compound annual growth rate of 5.64 percent forecasted from 2025 to 2035, understanding the intricate dynamics of the Distribution Channel will be vital for industry stakeholders aiming to capture a larger portion of the Global Infection Control Market revenue.

Infection Control Market Regional Insights

The Global Infection Control Market is projected to experience substantial growth across various regions, with North America leading the charge, holding a market valuation of 15.0 USD Billion in 2024 and expected to rise to 28.5 USD Billion by 2035. This region's dominance is attributed to advanced healthcare infrastructure and high adoption rates of innovative infection control technologies. Europe follows, with a valuation of 10.5 USD Billion in 2024, growing to 19.9 USD Billion by 2035, reflecting an increasing emphasis on stringent regulations and healthcare standards.The Asia Pacific (APAC) region is also notable, projected to rise from 7.0 USD Billion to 13.3 USD Billion, driven by the rapid expansion of healthcare facilities and increasing awareness about infection prevention. South America and the Middle East and Africa (MEA) currently demonstrate smaller market sizes, with South America valued at 2.0 USD Billion and MEA at 1.15 USD Billion in 2024, expected to grow to 3.8 USD Billion and 2.7 USD Billion respectively by 2035. The slower growth in these regions can be linked to economic challenges and varying healthcare priorities. Nonetheless, they present opportunities for expansion as healthcare access improves and the focus on infection control gains traction.Overall, the Global Infection Control Market segmentation by region highlights the varied dynamics and growth potential within each area, showcasing a wide-ranging landscape for market participants to explore growth opportunities in the infection control industry.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Infection Control Market Key Players and Competitive Insights

The Global Infection Control Market is characterized by a dynamic landscape driven by technological advancements, regulatory pressures, and an increasing emphasis on patient safety across various healthcare settings. With rising awareness regarding hospital-acquired infections and the need for stringent infection control measures, numerous companies are vying for a significant share of this burgeoning market. Competitive insights reveal that there is a growing focus on product innovation, strategic collaborations, mergers and acquisitions, and cost-effective solutions to address the rising demands of healthcare facilities worldwide. The competitive environment is primarily influenced by various factors, including changing consumer preferences, advancements in sterilization technologies, and improving healthcare infrastructure, which together shape the strategies of leading players in the market.Medline Industries has established itself as a formidable player in the Global Infection Control Market, presenting a strong portfolio of products and services aimed at reducing infection risks in healthcare settings. The company's strengths lie in its robust distribution network and a comprehensive range of medical supplies, including personal protective equipment, sterilization products, and surgical instruments. Medline Industries has also invested significantly in research and development, which has allowed it to innovate and adapt to the evolving challenges faced by healthcare providers in infection prevention. Their ability to leverage strong relationships with healthcare providers enhances their market presence, making them a key contributor to infection control practices globally.Getinge has a prominent standing in the Global Infection Control Market, offering a wide array of products and services designed to enhance safety during surgical and medical procedures. The company specializes in infection control solutions, including sterilizers, disinfectors, and cleaning products tailored for diverse healthcare environments. Getinge's strengths stem from its commitment to innovation and patient safety, along with a strong focus on quality and regulatory compliance. The company has a substantial market presence, reinforced by strategic mergers and acquisitions that expand its operational capabilities and product offerings. By continuously evolving its solutions and maintaining a strong alignment with healthcare trends, Getinge effectively addresses the complex needs of infection control on a global scale.

Key Companies in the Infection Control Market Include

• Medline Industries


• Getinge


• Ecolab


• Thermo Fisher Scientific


• BSN Medical


• Johnson and Johnson


• Kimberly-Clark


• Steris


• Crosstex International


• Becton Dickinson


• Purdue Pharma


• Cardinal Health


• 3M


• Hygiena

Infection Control Market Industry Developments

The Global Infection Control Market has been witnessing significant developments recently, largely driven by the increasing demand for healthcare safety and hygiene measures. In July 2023, Medline Industries announced a partnership with Cardinal Health to enhance its product offerings in surgical and post-surgical infection control solutions. Meanwhile, Getinge's acquisition of a smaller firm specializing in advanced sterilization technologies was reported in June 2023, aiming to strengthen their market position. Ecolab has also noted substantial growth in its infection prevention segment, driven by increased healthcare investments globally. At the same time, Thermo Fisher Scientific has expanded its portfolio through the launch of innovative infection control tools in September 2023. Major companies like 3M and Becton Dickinson have reported significant growth in their disinfectants and surgical products segments, reflecting a market shift towards more effective infection control solutions. In the last 2-3 years, the Global Infection Control Market has expanded significantly, with Kimberly-Clark and Steris increasing sales due to rising awareness around cleanliness and sanitation in medical facilities following the COVID-19 pandemic.

Infection Control Market Segmentation Insights

Infection Control Market Product Type Outlook

• Disinfectants


• Infection Control Supplies


• Sterilization Equipment


• Personal Protective Equipment

Infection Control Market Application Outlook

• Hospitals


• Pharmaceuticals


• Research Laboratories


• Food Industry

Infection Control Market End-Use Outlook

• Healthcare


• Commercial


• Residential

Infection Control Market Distribution Channel Outlook

• Online


• Offline


• Direct Sales

Infection Control Market Regional Outlook

• North America


• Europe


• South America


• Asia-Pacific


• Middle-East and Africa

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	33.75(USD Billion)
MARKET SIZE 2024	35.65(USD Billion)
MARKET SIZE 2035	65.2(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	5.64% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Medline Industries, Getinge, Ecolab, Thermo Fisher Scientific, BSN medical, Johnson and Johnson, KimberlyClark, Steris, Crosstex International, Becton Dickinson, Purdue Pharma, Cardinal Health, 3M, Hygiena
SEGMENTS COVERED	Product Type, Application, End Use, Distribution Channel, Regional
KEY MARKET OPPORTUNITIES	Rising demand for advanced disinfectants, Increasing focus on healthcare safety standards, Growth in surgical procedures worldwide, Expansion of telemedicine and remote care, Innovations in infection prevention technologies
KEY MARKET DYNAMICS	rising healthcare-associated infections , increasing need for sterilization , growing elderly population , technological advancements in infection control , stringent regulatory frameworks
COUNTRIES COVERED	North America, Europe, APAC, South America, MEA